Key statistics
On Tuesday, Xilio Therapeutics Inc (XLO:NSQ) closed at 0.7522, 53.51% above the 52 week low of 0.49 set on Dec 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.7815 |
---|---|
High | 0.8249 |
Low | 0.751 |
Bid | 0.7501 |
Offer | 0.8211 |
Previous close | 0.80 |
Average volume | 107.95k |
---|---|
Shares outstanding | 43.95m |
Free float | 25.96m |
P/E (TTM) | -- |
Market cap | 35.16m USD |
EPS (TTM) | -2.11 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
- Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
- Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
- Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
- Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
- Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
- Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
- Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
- Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference
More ▼